Cushing's syndrome (CS), or chronic hypercortisolism, induces a variety of alterations in the
immune system, often leading to severe clinical complications such as sepsis and …

Endogenous pathologic hypercortisolism, or Cushing's syndrome, is associated with poor
quality of life, morbidity, and increased mortality. Early diagnosis may mitigate against this …

Cushing's syndrome is a serious endocrine disease caused by chronic, autonomous, and
excessive secretion of cortisol. The syndrome is associated with increased mortality and …

Objective: Although increased central fat mass is characteristic of active Cushing's syndrome
(CS), little is known about body composition and secretion of adipokines after long-term …

Objective Cushing's syndrome is associated with several comorbidities responsible for the
increased cardiovascular risk, not only during the active phase but also after disease …

Cushing's syndrome (CS) patients have increased mortality primarily due to cardiovascular
events induced by glucocorticoid (GC) excess-related severe metabolic changes. Glucose …

The prevailing notion has been that cytokines such as interleukin-1 released from sites of
inflammation cross the blood–brain barrier and drive the hypothalamo–pituitary–adrenal …

Context: Cushing's syndrome (CS) is associated with hypercoagulability, insulin resistance,
hypertension, bone loss, and immunosuppression. To date, no adequately large cohort …

Introduction Cushing's disease is a rare disorder characterized by overproduction of ACTH
from a pituitary adenoma leading to hypercortisolemia that in turn leads to increased …

Cushing's syndrome is associated with increased mortality, mainly due to cardiovascular
complications, which are sustained by the common development of systemic arterial …